Recurrence and mortality among patients hospitalized for acute lower gastrointestinal bleeding

Clinical Gastroenterology and Hepatology

Volumn 13, Issue 3, 2015, Pages 488-494.e1

  Aoki, Tomonori ^a   Nagata, Naoyoshi ^a   Niikura, Ryota ^a   Shimbo, Takuro ^a   Tanaka, Shohei ^a   Sekine, Katsunori ^a   Kishida, Yoshihiro ^a   Watanabe, Kazuhiro ^a   Sakurai, Toshiyuki ^a   Yokoi, Chizu ^a   Akiyama, Junichi ^a   Yanase, Mikio ^a   Mizokami, Masashi ^b   Uemura, Naomi ^b  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b National Center for Global Health and Medicine   (Japan)

Author keywords

Anticoagulants; Antithrombotic agents; LGIB; Lower gastrointestinal hemorrhage; Mortality; Poor clinical outcomes; Recurrence

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; DIPYRIDAMOLE; NONSTEROID ANTIINFLAMMATORY AGENT; TICLOPIDINE; WARFARIN; ANTICOAGULANT AGENT; ANTIINFLAMMATORY AGENT; ANTITHROMBOCYTIC AGENT;

AGE; AGED; ANTICOAGULANT THERAPY; ARTICLE; CHARLSON COMORBIDITY INDEX; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HIGH RISK PATIENT; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; RECURRENCE RISK; RECURRENT DISEASE; RETROSPECTIVE STUDY; ADULT; HOSPITALIZATION; JAPAN; MIDDLE AGED; RISK FACTOR; SURVIVAL ANALYSIS; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; ANTICOAGULANTS; ASPIRIN; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITALIZATION; HUMANS; JAPAN; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; WARFARIN;

EID: 84925340342     PISSN: 15423565     EISSN: 15427714     Source Type: Journal    
DOI: 10.1016/j.cgh.2014.06.023     Document Type: Article

References (31)

1. Lanas A., Garcia-Rodriguez L.A., Polo-Tomas M., et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol 2009, 104:1633-1641.
2. Longstreth G.F. Epidemiology and outcome of patients hospitalized with acute lower gastrointestinal hemorrhage: a population-based study. Am J Gastroenterol 1997, 92:419-424.
3. Chait M.M. Lower gastrointestinal bleeding in the elderly. World J Gastrointest Endosc 2010, 2:147-154.
4. Strate L.L., Ayanian J.Z., Kotler G., et al. Risk factors for mortality in lower intestinal bleeding. Clin Gastroenterol Hepatol 2008, 6:1004-1010. quiz 955.
5. Wilcox C.M., Clark W.S. Causes and outcome of upper and lower gastrointestinal bleeding: the Grady Hospital experience. South Med J 1999, 92:44-50.
6. Edelman D.A., Sugawa C. Lower gastrointestinal bleeding: areview. Surg Endosc 2007, 21:514-520.
7. Anthony T., Penta P., Todd R.D., et al. Rebleeding and survival after acute lower gastrointestinal bleeding. Am J Surg 2004, 188:485-490.
8. Bhatt D.L., Scheiman J., Abraham N.S., et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol 2008, 103:2890-2907.
9. Kaplan R.C., Heckbert S.R., Psaty B.M. Risk factors for hospitalized upper or lower gastrointestinal tract bleeding in treated hypertensives. Prev Med 2002, 34:455-462.
10. Laine L., Smith R., Min K., et al. Systematic review: the lowergastrointestinal adverse effects of non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther 2006, 24:751-767.
11. Wilcox C.M., Alexander L.N., Cotsonis G.A., et al. Nonsteroidal antiinflammatory drugs are associated with both upper and lower gastrointestinal bleeding. Dig Dis Sci 1997, 42:990-997.
12. Hreinsson J.P., Gumundsson S., Kalaitzakis E., et al. Lower gastrointestinal bleeding: incidence, etiology, and outcomes in a population-based setting. Eur J Gastroenterol Hepatol 2013, 25:37-43.
13. Charlson M.E., Pompei P., Ales K.L., et al. Anew method of classifying prognostic comorbidity in longitudinal studies: development and validation. JChronic Dis 1987, 40:373-383.
14. Charlson M., Szatrowski T.P., Peterson J., et al. Validation of a combined comorbidity index. JClin Epidemiol 1994, 47:1245-1251.
15. Sung J.J., Tsoi K.K., Ma T.K., et al. Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases. Am J Gastroenterol 2010, 105:84-89.
16. Anderson M.A., Ben-Menachem T., et al. Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc 2009, 70:1060-1070. ASGE Standards of Practice Committee.
17. Fine J., Gray R. Aproportional hazards model for the subdistribution of a competing risk. JAm Stat Assoc 1999, 94:496-509.
18. Poncet G., Heluwaert F., Voirin D., et al. Natural history of acute colonic diverticular bleeding: a prospective study in 133 consecutive patients. Aliment Pharmacol Ther 2010, 32:466-471.
19. Okamoto T., Watabe H., Yamada A., et al. The association between arteriosclerosis related diseases and diverticular bleeding. Int J Colorectal Dis 2012, 27:1161-1166.
20. Niikura R., Nagata N., Yamada A., et al. Recurrence of colonic diverticular bleeding and associated risk factors. Colorectal Dis 2012, 14:302-305.
21. Nishikawa H., Maruo T., Tsumura T., et al. Risk factors associated with recurrent hemorrhage after the initial improvement of colonic diverticular bleeding. Acta Gastroenterol Belg 2013, 76:20-24.
22. Tanaka H., Ueda Y., Date C., et al. Incidence of stroke in Shibata, Japan: 1976-1978. Stroke 1981, 12:460-466.
23. Kubo M., Kiyohara Y., Kato I., et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke 2003, 34:2349-2354.
24. Uotani T., Sugimoto M., Nishino M., et al. Ability of rabeprazole to prevent gastric mucosal damage from clopidogrel and low doses of aspirin depends on CYP2C19 genotype. Clin Gastroenterol Hepatol 2012, 10:879-885.e2.
25. Delaney J.A., Opatrny L., Brophy J.M., et al. Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. CMAJ 2007, 177:347-351.
26. Hallas J., Dall M., Andries A., et al. Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study. BMJ 2006, 333:726.
27. Bjarnason I., Hayllar J., MacPherson A.J., et al. Side effectsof nonsteroidal anti-inflammatory drugs on the small andlarge intestine in humans. Gastroenterology 1993, 104:1832-1847.
28. Higuchi K., Umegaki E., Watanabe T., et al. Present status and strategy of NSAIDs-induced small bowel injury. JGastroenterol 2009, 44:879-888.
29. Strate L.L., Liu Y.L., Aldoori W.H., et al. Obesity increases the risks of diverticulitis and diverticular bleeding. Gastroenterology 2009, 136:115-122.e1.
30. Longstreth G.F., Yao J.F. Diseases and drugs that increase risk of acute large bowel ischemia. Clin Gastroenterol Hepatol 2010, 8:49-54.
31. Ahsberg K., Hoglund P., Kim W.H., et al. Impact of aspirin, NSAIDs, warfarin, corticosteroids and SSRIs on the site and outcome of non-variceal upper and lower gastrointestinal bleeding. Scand J Gastroenterol 2010, 45:1404-1415.